Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 12, keine Gesamtzahl für „Diarrhoea“
Suchtreffer
Begriffe & Kennungen
Kivexa · 4.8 · Gastrointestinal tract Nausea, vomiting, diarrhoea, abdominal pain, mouth ulceration
Eintrag öffnenKoselugo · 4.8 · Gastrointestinal toxicities In the NF1-PN Paediatric Pool (N=126), vomiting (78 patients, 62%), diarrhoea (71
Eintrag öffnenKoselugo · 4.8 · Gastrointestinal toxicities In the NF1-PN Paediatric Pool (N=126), vomiting (78 patients, 62%), diarrhoea (71
Eintrag öffnenKoselugo · 4.8 · In the NF1-PN adult patients (N = 137), diarrhoea (41 patients, 30%), vomiting (27 patients, 20%), nausea (23
Eintrag öffnenKoselugo · 4.8 · In the NF1-PN adult patients (N = 137), diarrhoea (41 patients, 30%), vomiting (27 patients, 20%), nausea (23
Eintrag öffnenKoselugo · 4.8 · Vomiting ^ Very common Common (7%) Very common - (62%) (20%) Diarrhoea ^ Very common Very common Very common -
Eintrag öffnenKoselugo · 4.8 · Vomiting ^ Very common Common (7%) Very common - (62%) (20%) Diarrhoea ^ Very common Very common Very common -
Eintrag öffnenKrazati · 4.8 · Diarrhoea, nausea and vomiting resulted in dose interruption or reduction in 13.3%, 14.7% and 13.4% of patient
Eintrag öffnenKrazati · 4.8 · The most common adverse reactions are diarrhoea (65.2%), nausea (59.9%), fatigue (54.3%), vomiting (50.3%), de
Eintrag öffnenKrazati · 4.8 · The most common adverse reactions leading to dose reduction or interruption are nausea (14.7%), diarrhoea (13.
Eintrag öffnenKuvan · 4.8 · Gastrointestinal disorders Common: Diarrhoea, vomiting, abdominal pain, dyspepsia, nausea Not known: Gastritis
Eintrag öffnenKuvan · 4.8 · Gastrointestinal disorders Common: Diarrhoea, vomiting, abdominal pain, dyspepsia, nausea Not known: Gastritis
Eintrag öffnenKygevvi · 4.8 · Gastrointestinal disturbances Gastrointestinal disturbances such as diarrhoea, vomiting, and abdominal pain (i
Eintrag öffnenKygevvi · 4.8 · The most commonly reported adverse reactions were diarrhoea (86%), vomiting (28%), abdominal pain (including a
Eintrag öffnenKyntheum · 4.8 · The most commonly reported adverse reactions are arthralgia (4.6%), headache (4.3%), fatigue (2.6%), diarrhoea
Eintrag öffnenLamivudine Teva Pharma B.V. · 4.8 · Gastrointestinal disorders Common: Nausea, vomiting, abdominal pain or cramps, diarrhoea. Rare: Pancreatitis,
Eintrag öffnenLamzede · 4.8 · The most common adverse reactions observed were weight increase (15%), IRRs (13%), diarrhoea (10%), headache (
Eintrag öffnenLangwierige Diarrhöe
Eintrag öffnenLazcluze · 4.8 · Diarrhoea
Eintrag öffnenLazcluze · 4.8 · Diarrhoea occurred in 29% of patients treated with lazertinib in combination with amivantamab. Most events wer
Eintrag öffnen